HealthTree Logo
search more_vert
close
person Sign In / Create Account
Elranatamab - Therapies On The Horizon
Posted: May 09, 2023
Elranatamab - Therapies On The Horizon image

HealthTree University: Therapies On The Horizon - Elranatamab

Therapies On The Horizon is a new course introducing the newest upcoming therapies being researched in multiple myeloma. Elranatamab is one of these upcoming therapies. It is a bi-specific T-cell engaging antibody and works by getting the patient's immune cells to attack cancer cells directly. It is an off-the-shelf treatment that can be given right when the patient needs it. Watch the video below for more information! You can watch the full course on HealthTree University.

42.01    Elranatamab

 

We’d like to thank our faculty who donated their time in creating these videos, including:

  • Dan Vogl, MD, MSCE
  • Guenther Koehne, MD, PHD

Want more?

We have over 500 HealthTree University videos online at HealthTree University! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!

 

The author Cynthia Chmielewski

about the author
Cynthia Chmielewski

Cynthia (Cindy) Chmielewski is a professional educator and myeloma advocate. As a former teacher, she now teaches myeloma patients how to advocate for themselves as the Director of HealthTree University. You can follow her on Twitter @myelomateacher

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Regeneron
Adaptive
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube